SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000939767-24-000002
Filing Date
2024-01-08
Accepted
2024-01-08 09:06:06
Documents
15
Period of Report
2024-01-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20240102.htm   iXBRL 8-K 34210
2 EX-99.1 exel20240108exhibit991.htm EX-99.1 59373
6 exel-20240102_g1.jpg GRAPHIC 55431
7 exelixis_logoxrgbx2023.jpg GRAPHIC 55431
  Complete submission text file 0000939767-24-000002.txt   445311

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20240102.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20240102_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20240102_pre.xml EX-101.PRE 12522
9 EXTRACTED XBRL INSTANCE DOCUMENT exel-20240102_htm.xml XML 2708
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 24518611
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)